HDAC9 and prostate carcinoma: Promotion of HDAC activity [162]Resveratrol targets: SIRT1, -2 and -3 [162]H3 acetylation in breast cancer, enhancing the expression of BRCA1 [144]FOXO deacetylation in prostate cancer [163]Reduction in the expression of different oncogenic miRNAs in colon cancer cells [144]